×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Psychedelic Companies Tripping Over Debt Payments
Green Market Report
Psychedelic companies are using stock to pay debts. Even some vendors are having to take stock instead of cash for payment.
14 months ago
Spore Acquisition Gives Havn Life Sciences An Industry-Leading Revenue Profile
Yahoo Finance
With its recent definitive agreement to acquire Spore Life Sciences, Havn will acquire a business with significant recurring revenue and even...
27 months ago
HAVN Life To Be Featured On Viewpoint with Dennis Quaid
PR Newswire
PRNewswire/ - HAVN Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the "Company" or "HAVN Life") a biotechnology company pursuing...
23 months ago
What Value Will Ex-Aphria CEO Vic Neufeld Bring to Havn Life Sciences?
The Dales Report
In part one of our two part series Vic Neufeld explains the many reasons why the industry has captivated his attention.
44 months ago
Havn Life to Cultivate Psilocybin in Jamaica through Hypha Wellness Partnership
Psychedelic Spotlight
Havn Life Sciences is expanding its psilocybin cultivation in Jamaica where the psychedelic mushrooms are legal to grow.
34 months ago
HAVN Life Successfully Exports Psilocybin from its Jamaica Facility into Canada
Canada Newswire
CNW/ - Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the "Company" or "Havn Life") a biotechnology company pursuing...
30 months ago
North American Psychedelics Index Published: Which Companies Will Be in the First Psychedelic ETF?
Psychedelic Alpha
Update (Jan 22nd, 2021): Horizons has confirmed that there is no 15% performance fee, contrary to that present in the ETF Facts sheet filed via Sedar.
24 months ago
Psychedelics Startups Racing to Go Public: Compass, Havn, Field Trip
Business Insider
The psychedelics industry is booming, drawing attention from biotech investors, as well as from cannabis companies.
43 months ago
Global Psychedelic Drugs Market Size To Worth USD 8.7 Billion By 2033 | CAGR of 11.61%
GlobeNewswire
The Global Psychedelic Drugs Market Size was Valued at USD 2.9 Billion in 2023 and the Worldwide Psychedelic Drugs Market Size is Expected...
2 months ago